|
Volumn 10, Issue 1, 2001, Pages 16-21
|
Renal cell carcinoma and malignant phase hypertension
a a a a a a a |
Author keywords
Malignant hypertension; Renal carcinoma
|
Indexed keywords
ALDOSTERONE;
AMLODIPINE;
ANTIBIOTIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTINEOPLASTIC AGENT;
ATENOLOL;
CHLORAMBUCIL;
CREATININE;
DOXAZOSIN;
FUROSEMIDE;
HEMOGLOBIN;
IMMUNOSUPPRESSIVE AGENT;
NIFEDIPINE;
PLASMA PROTEIN;
POTASSIUM;
RENIN;
SODIUM;
ADULT;
AGED;
ARTICLE;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CASE CONTROL STUDY;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
FEMALE;
FOLLOW UP;
HEALTH SURVEY;
HUMAN;
KIDNEY CANCER;
KIDNEY CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
MALIGNANT HYPERTENSION;
MEDICAL LITERATURE;
NEPHRECTOMY;
POPULATION RESEARCH;
PREVALENCE;
PRIORITY JOURNAL;
PUBLICATION;
SCREENING TEST;
ADULT;
AGE FACTORS;
AGED;
CARCINOMA, RENAL CELL;
ENGLAND;
FEMALE;
HUMANS;
HYPERTENSION, MALIGNANT;
MALE;
MIDDLE AGED;
PREVALENCE;
RETROSPECTIVE STUDIES;
|
EID: 0035067605
PISSN: 08037051
EISSN: None
Source Type: Journal
DOI: 10.1080/080370501750183336 Document Type: Article |
Times cited : (1)
|
References (23)
|